TLON what do you thinking about raising A/S and the last 8K filling from tlon board ErnieBilco Member Profile ErnieBilco Member Level
Share Sunday, February 26, 2012 10:07:28 AM Re: None Post # of 2040 Appears they are getting their golden parachutes ready for a take over..... by the looks of the Feb 24th 8K.
I'm not happy that they were paid milestone bonuses for only hitting 40% of their milestone targets......... what does their base salary "compensate" for? Just showing up for work?
TLON..$.93 Key information from their 2010 ASCO presentation from their RALLY study. The data is far from "underwhelming" and is very impressive. This is in 3rd-6th line patients who had already been on regular vincristine. The results are significant in a disease with few options. This is why the FDA granted "accelerated approval." Accelerated meaning conditional approval with Phase II instead of Phase III data and not standard review to priority review. Priority review meant nothing to Talon if they could not get the confirmatory studies up and running in time. The extra 4 months (standard review) has given them time to get their studies in place. Still waiting on a pt to be enrolled in the HALLMARQ conf Phase III study. Standard review was best for Talon.
The FDA also gave them a SPA for their confirmatory Phase III study understanding that if they approved them on single trial Phase II data that the company would have sufficient time to demonstrate that their durable response would translate into a meaningful clinical benefit (i.e. increased survival advantage). This was the 56 pt study as the data has been updated to include the 65 pt study as well. Still solid data.
News 
Market Data 
Discover 
